Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Reduction of EGF receptor levels in human tumor cells transfected with an antisense RNA expression vector

Journal Article · · Experimental Cell Research; (United States)
; ;  [1];  [2]
  1. National Inst. of Industrial Health, Kawasaki (Japan)
  2. Keio Univ., Tokyo (Japan)
An expression vector was constructed from part of pSV2neo with the 3{prime}-ClaI fragment of the epidermal growth factor (EGF) receptor cDNA inserted in an inverted orientation downstream from the human metallothionein (MT) IIa promoter. The human squamous carcinoma cell line NA, which overproduces EGF receptor, was transfected with this vector and selected for resistance to the neomycin derivative G418. One of the stable transfectants had a 90% reduction cell-surface EGF receptor in response to ZnSO{sub 4}. The nascent EGF receptor peptide was also decreased with concurrent induction of MT mRNA. These data suggest that the antisense transcript regulated by the MT promoter inhibits the expression of the endogenous EGF receptor genes. Although no transcripts from the antisense gene were detected, the results indicate that transfection with the antisense vector provides a technique by which to modulate the number of EGF receptors on the cell surface of squamous cell carcinomas.
OSTI ID:
5533771
Journal Information:
Experimental Cell Research; (United States), Journal Name: Experimental Cell Research; (United States) Vol. 184:1; ISSN ECREA; ISSN 0014-4827
Country of Publication:
United States
Language:
English